BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 27378554)

  • 1. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
    Mahla E; Metzler H; Bornemann-Cimenti H; Prueller F; Raggam RB; Pregartner G; Berghold A; Baumann A; Goeroeg C; Gurbel PA
    Thromb Haemost; 2018 May; 118(5):864-872. PubMed ID: 29625498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Do Type of Preoperative P2Y
    Voetsch A; Pregartner G; Berghold A; Seitelberger R; Schoerghuber M; Toller W; Mahla E
    Ann Thorac Surg; 2021 Jan; 111(1):77-84. PubMed ID: 32565086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
    Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
    Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization.
    Nakashima CAK; Dallan LAO; Lisboa LAF; Jatene FB; Hajjar LA; Soeiro AM; Furtado RHM; Dalçoquio TF; Baracioli LM; Lima FG; Giraldez RRCV; Silva BA; Costa MSS; Strunz CMC; Dallan LRP; Barbosa CJDG; Britto FAB; Farkouh ME; Gurbel PA; Nicolau JC
    J Am Coll Cardiol; 2021 Mar; 77(10):1277-1286. PubMed ID: 33706868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor.
    Mingant F; Didier R; Gilard M; Martin F; Nicol PP; Ugo V; Lippert E; Galinat H
    Platelets; 2018 May; 29(3):257-264. PubMed ID: 29580115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
    Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
    Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
    Nagashima Z; Tsukahara K; Uchida K; Hibi K; Karube N; Ebina T; Imoto K; Kimura K; Umemura S
    J Cardiol; 2017 Jan; 69(1):156-161. PubMed ID: 26987791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
    J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.
    Angiolillo DJ; Firstenberg MS; Price MJ; Tummala PE; Hutyra M; Welsby IJ; Voeltz MD; Chandna H; Ramaiah C; Brtko M; Cannon L; Dyke C; Liu T; Montalescot G; Manoukian SV; Prats J; Topol EJ;
    JAMA; 2012 Jan; 307(3):265-74. PubMed ID: 22253393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry.
    Della Corte A; Bancone C; Spadafora A; Borrelli M; Galdieri N; Quintiliano SN; Bifulco O; De Feo M
    Eur J Cardiothorac Surg; 2017 Nov; 52(5):901-908. PubMed ID: 28977378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of platelet reactivity on BARC classification in East Asian patients undergoing percutaneous coronary intervention. Results of the ACCEL-BLEED study.
    Kwon TJ; Tantry US; Park Y; Choi YM; Ahn JH; Kim KH; Koh JS; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Smith SC; Jeong YH
    Thromb Haemost; 2016 May; 115(5):979-92. PubMed ID: 26790469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
    Mahla E; Tantry US; Prüller F; Gurbel PA
    Circulation; 2018 Nov; 138(19):2145-2159. PubMed ID: 30474416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of preoperative treatment with aspirin or heparin on platelet function and intensity of postoperative bleeding in early period after coronary artery bypass surgery].
    Veikutiene A; Sirvinskas E; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V
    Medicina (Kaunas); 2005; 41(7):577-83. PubMed ID: 16062025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests.
    Woo KS; Kim BR; Kim JE; Goh RY; Yu LH; Kim MH; Han JY
    Korean J Lab Med; 2010 Oct; 30(5):460-8. PubMed ID: 20890076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does clopidogrel increase blood loss following coronary artery bypass surgery?
    Chu MW; Wilson SR; Novick RJ; Stitt LW; Quantz MA
    Ann Thorac Surg; 2004 Nov; 78(5):1536-41. PubMed ID: 15511426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine diphosphate-induced single-platelet count aggregation and bleeding in clopidogrel-treated patients undergoing coronary artery bypass grafting.
    Dalén M; van der Linden J; Holm M; Lindvall G; Ivert T
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):230-4. PubMed ID: 24447500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.